Shayma Master Kazmi, MD, RPh
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Cherry Hill
View 1 additional location
Make an appointmentCall 800-789-7366
Headshot of Shayma Master Kazmi, MD, RPh
Penn Medicine Provider

About me

Education and training

  • Medical School: University Of Medicine & Dentistry Of New Jersey - Piscataway
  • Residency: Rutgers-Robert Wood Johnson Medical School

What my patients think about me

Average Rating

1115 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
Dr. Kazmi was particularly kind, she answered all my questions. she was not in a hurry to dismiss me
February 2026
dr kazmi is extremely smart and knowledgeable about lung cancer. she explained everything clearly and answered all of my questions and concerns.
February 2026
nice dr
February 2026
doctor expertise

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kazmi is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Kazmi, S The Role of Antibody Drug Conjugates in Non Small Cell Lung Cancer , Oncology Times, 44(2): 2022

Kazmi, S Burnout is Cancer , ASCO Connection: 2021

Kazmi, S, Chatterjee, D, Raju, D, Hauser, R, Kaufman, P Overall Survival Analysis in Patients with metastatic breast cancer and liver or lung metastases treated with Eribulin, Gemcitabine or Capecitabine , Breast Cancer Research and Treatment: 2020

kazmi, S, Wagner, S, Heintzelman, R, Corbman, M Malignant Phyllodes in Lynch Syndrome: a case report , Journal of Medical Case Reports: 2019

Kazmi, S, Ferraro, J My Transformational Experience in a Physician forum group , Oncology Times: 2018

Alvarez, R, et al, Kazmi, S Therapeutic Efficacy of Off label Targeted Agents Utilization Based molecular profiling in advanced cancer patients , ASCO abstract : 2018

kazmi, S A retrospective analysis to evaluate prevalence and correlation between PDL1 score and TMB in patients with solid tumor malignancies , ESMO abstract/poster: 2017

Kazmi, S A retrospective analysis of response to checkpoint inhibitors and its correlation to both PDL1 score and TMB in patients with solid tumor malignancies , ESMO poster/abstract: 2017